芯片股集體降温!兆易創新(603986.SH)等多股跌停
格隆匯3月4日丨A股市場芯片股集體下跌,其中,兆易創新、雅克科技、上海新陽跌停,科創板中微公司跌超10%,賽騰股份、晶方科技、通富微電、北方華創、北京君正等均逼近跌停。值得注意的是,目前跌幅較大的芯片股均是此前累計漲幅較大的個股。其中,兆易創新跌停後市值仍有1012億元,該股一度自2019年10月由132元上漲至2020年2月25日的428元,4個月期間累漲220%。2月26日,兆易創新公告,因個人資金需求,公司代理總經理何衞、副總經理、董事會祕書、財務負責人李紅、副總經理陳永波、副總經理鄭濤計劃減持7.67萬股,即不超過0.0239%公司股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.